Article
Subscribe
In this first session, the experts discuss their standard approach when using ranibizumab (Lucentis, Genentech) to treat their patients with age-related macular degeneration.
Participants include:
Return to Retina Roundtable Podcast Series
Return to Ophthalmology Times Radio